Clinical Trials Browser

Observational × Has results × Standard of Care × Clear all

NCT06504524 2025-06-27

A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Multiple Myeloma (MM) in Germany and US

633 enrolled 15 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT05236257 2024-12-10

EPI VITRAKVI

93 enrolled 14 charts

Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion

NCT05932290 2024-10-29

A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma

514 enrolled 16 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT05565391 2024-05-21

A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma

508 enrolled 16 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01254318 2016-11-02

TRAFIC

130 enrolled 5 charts

Other hematologic neoplasm

Leukemia, Mycoses, Hematologic Neoplasms